🇮🇳 India Warehouse PAROXETINE — 25mg per tablet, 105-count pack. SSRI for MDD, OCD, panic disorder, social anxiety, PTSD, GAD, and menopausal hot flashes (Brisdelle brand). Most potent SSRI for anxiety disorders.
Key warning: Worst discontinuation syndrome among SSRIs — taper very slowly over weeks to months. CYP2D6 inhibitor — multiple drug interactions. Do NOT combine with tamoxifen (reduces active endoxifen). MAOIs contraindicated.
🇮🇳 India Warehouse PAROXETINE — 37.5mg per tablet, 100-count pack. SSRI for MDD, OCD, panic disorder, social anxiety, PTSD, GAD, and menopausal hot flashes (Brisdelle brand). Most potent SSRI for anxiety disorders.
Key warning: Worst discontinuation syndrome among SSRIs — taper very slowly over weeks to months. CYP2D6 inhibitor — multiple drug interactions. Do NOT combine with tamoxifen (reduces active endoxifen). MAOIs contraindicated.
🇮🇳 India Warehouse CEPHALEXIN — 750mg per tablet, 100-count pack. First-generation cephalosporin for skin/soft tissue infections, UTIs, streptococcal pharyngitis, otitis media, and surgical prophylaxis. Good gram-positive coverage.
Key warning: Penicillin allergy — cross-reactivity risk (less than 1% but history important). Dose adjust in renal impairment. Increasing MRSA prevalence limits utility for skin infections in some regions.
🇮🇳 India Warehouse PALBOCICLIB — 100mg per tablet, 105-count pack. CDK4/6 inhibitor for hormone receptor-positive, HER2-negative advanced/metastatic breast cancer — combined with letrozole or fulvestrant as standard first and second-line treatment.
Key warning: CBC monitoring mandatory (weekly for first 2 cycles, monthly thereafter). Dose reductions for grade 3/4 neutropenia. QT prolongation risk. CYP3A4 substrate — multiple interactions. Embryofetal toxicity.
🇮🇳 India Warehouse PIOGLITAZONE — 15mg per tablet, 100-count pack. Thiazolidinedione insulin sensitizer for type 2 diabetes. Evidence in NASH/NAFLD (liver fat reduction), PCOS, and potentially neuroprotective applications.
Key warning: Contraindicated in heart failure (NYHA Class III/IV). Bladder cancer association — avoid with bladder cancer history. Fluid retention worsens with insulin. Bone fracture risk monitoring in women.
🇮🇳 India Warehouse PIOGLITAZONE — 30mg per tablet, 100-count pack. Thiazolidinedione insulin sensitizer for type 2 diabetes. Evidence in NASH/NAFLD (liver fat reduction), PCOS, and potentially neuroprotective applications.
Key warning: Contraindicated in heart failure (NYHA Class III/IV). Bladder cancer association — avoid with bladder cancer history. Fluid retention worsens with insulin. Bone fracture risk monitoring in women.
🇮🇳 India Warehouse PIOGLITAZONE — 7.5mg per tablet, 100-count pack. Thiazolidinedione insulin sensitizer for type 2 diabetes. Evidence in NASH/NAFLD (liver fat reduction), PCOS, and potentially neuroprotective applications.
Key warning: Contraindicated in heart failure (NYHA Class III/IV). Bladder cancer association — avoid with bladder cancer history. Fluid retention worsens with insulin. Bone fracture risk monitoring in women.
🇮🇳 India Warehouse PIOGLITAZONE — 15mg per tablet, 100-count pack. Thiazolidinedione insulin sensitizer for type 2 diabetes. Evidence in NASH/NAFLD (liver fat reduction), PCOS, and potentially neuroprotective applications.
Key warning: Contraindicated in heart failure (NYHA Class III/IV). Bladder cancer association — avoid with bladder cancer history. Fluid retention worsens with insulin. Bone fracture risk monitoring in women.
🇮🇳 India Warehouse PIOGLITAZONE — 30mg per tablet, 100-count pack. Thiazolidinedione insulin sensitizer for type 2 diabetes. Evidence in NASH/NAFLD (liver fat reduction), PCOS, and potentially neuroprotective applications.
Key warning: Contraindicated in heart failure (NYHA Class III/IV). Bladder cancer association — avoid with bladder cancer history. Fluid retention worsens with insulin. Bone fracture risk monitoring in women.
🇮🇳 India Warehouse PIOGLITAZONE — 7.5mg per tablet, 100-count pack. Thiazolidinedione insulin sensitizer for type 2 diabetes. Evidence in NASH/NAFLD (liver fat reduction), PCOS, and potentially neuroprotective applications.
Key warning: Contraindicated in heart failure (NYHA Class III/IV). Bladder cancer association — avoid with bladder cancer history. Fluid retention worsens with insulin. Bone fracture risk monitoring in women.
🇮🇳 India Warehouse PIRFENIDONE — 200mg per tablet, 100-count pack. Antifibrotic for idiopathic pulmonary fibrosis (IPF) — slows rate of lung function decline. First oral therapy approved specifically for IPF.
🇮🇳 India Warehouse PIRFENIDONE — 200mg per tablet, 105-count pack. Antifibrotic for idiopathic pulmonary fibrosis (IPF) — slows rate of lung function decline. First oral therapy approved specifically for IPF.
🇮🇳 India Warehouse PIRFENIDONE — 400mg per tablet, 105-count pack. Antifibrotic for idiopathic pulmonary fibrosis (IPF) — slows rate of lung function decline. First oral therapy approved specifically for IPF.
🇮🇳 India Warehouse PIRFENIDONE — 600mg per tablet, 105-count pack. Antifibrotic for idiopathic pulmonary fibrosis (IPF) — slows rate of lung function decline. First oral therapy approved specifically for IPF.
🇮🇳 India Warehouse PIRFENIDONE — 801mg per tablet, 100-count pack. Antifibrotic for idiopathic pulmonary fibrosis (IPF) — slows rate of lung function decline. First oral therapy approved specifically for IPF.
🇮🇳 India Warehouse PIRFENIDONE — 200mg per tablet, 100-count pack. Antifibrotic for idiopathic pulmonary fibrosis (IPF) — slows rate of lung function decline. First oral therapy approved specifically for IPF.
🇮🇳 India Warehouse APIXABAN — 25mg per tablet, 105-count pack. Stroke prevention in non-valvular atrial fibrillation, DVT/PE treatment and prevention, and post-surgical thromboprophylaxis. Preferred over warfarin for predictable dosing without monitoring.
Key warning: Reversal agent available but expensive. Avoid strong CYP3A4/P-gp inhibitors (ketoconazole, ritonavir). Reduce dose in renal impairment. Hold 24–48h before surgery. No routine monitoring required.
🇮🇳 India Warehouse APIXABAN — 50mg per tablet, 105-count pack. Stroke prevention in non-valvular atrial fibrillation, DVT/PE treatment and prevention, and post-surgical thromboprophylaxis. Preferred over warfarin for predictable dosing without monitoring.
Key warning: Reversal agent available but expensive. Avoid strong CYP3A4/P-gp inhibitors (ketoconazole, ritonavir). Reduce dose in renal impairment. Hold 24–48h before surgery. No routine monitoring required.